Evaluation of cycle threshold values at deisolation.

Area of Science:

• Infectious Diseases
• Clinical Medicine
• Virology

Background:

• Hospitalized patients with severe acute respiratory coronavirus virus 2 (SARS-CoV-2) may have persistent positive molecular test results.
• Decisions regarding the discontinuation of isolation for these patients are complex.

Purpose of the Study:

• To explore the nuanced factors influencing the decision to discontinue isolation in hospitalized patients with persistently positive SARS-CoV-2 molecular testing.
• To highlight the role of clinical improvement and expert consultation in this decision-making process.

Main Methods:

• Review of clinical guidelines and expert opinion on SARS-CoV-2 isolation protocols.
• Analysis of the utility of molecular testing parameters, such as cycle threshold (Ct) values, in conjunction with clinical assessment.

Main Results:

• Discontinuation of isolation is not solely based on persistent positive molecular tests.
• Clinical status improvement is a primary consideration, often requiring expert medical advice.
• Cycle threshold values can provide supplementary information to guide isolation decisions.

Conclusions:

• The decision to stop isolation for patients with persistent SARS-CoV-2 positivity is multifactorial.
• Integrating clinical assessment, expert consultation, and molecular data like Ct values optimizes patient care and resource allocation.
• Further research may refine criteria for isolation discontinuation in specific patient populations.